Drug recall · June 29, 2016
Dicloxacillin Sodium Capsules USP recall
Why: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dicloxacillin Sodium Capsules USP, 500mg, Rx Only, 100 Capsule bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc. , Princeton, NJ 08540, Product of Spain, NDC 0781-2258-01
- Lots / codes
Lot #: EN0389, EP0473, Exp. 8/2016 ; FA4834, FN2602, Exp. 2/2017; FW3646 , Exp.11/2017
- Quantity
- N/A
- Company
- Sandoz, Inc, Princeton, NJ
- Distribution
- Nationwide
- Initiated
- May 2, 2016 · Voluntary: Firm initiated
- Classified
- June 20, 2016
- Reported
- June 29, 2016
- Ended
- August 17, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dicloxacillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.